These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 980114)

  • 21. Dissociable properties of dopamine neurons im the nigrostriatal and mesolimbic dopamine systems.
    Koob GF; Del Fiacco M; Iversen SD
    Adv Biochem Psychopharmacol; 1977; 16():589-95. PubMed ID: 560793
    [No Abstract]   [Full Text] [Related]  

  • 22. Dopamine antagonist binding increases in two behaviorally distinct striatal denervation syndromes.
    Thal L; Mishra RK; Gardner EL; Horowitz SG; Varmuza S; Makman MH
    Brain Res; 1979 Jul; 170(2):381-6. PubMed ID: 572733
    [No Abstract]   [Full Text] [Related]  

  • 23. Mesocortical dopamine neurons: rapid transmitter turnover compared to other brain catecholamine systems.
    Bannon MJ; Bunney EB; Roth RH
    Brain Res; 1981 Aug; 218(1-2):376-82. PubMed ID: 7272743
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Interactions of exogenous L-dopa with nigrostriatal dopaminergic neurons in Parkinson's disease.
    Melamed E
    Adv Neurol; 1990; 53():61-6. PubMed ID: 2173376
    [No Abstract]   [Full Text] [Related]  

  • 25. Reconstruction of the nigrostriatal dopamine pathway by intracerebral nigral transplants.
    Björklund A; Stenevi U
    Brain Res; 1979 Nov; 177(3):555-60. PubMed ID: 574053
    [No Abstract]   [Full Text] [Related]  

  • 26. Effect of p-chloroamphetamine and 5,7-dihydroxytryptamine on rotation and dopamine turnover.
    Giambalvo CT; Snodgrass SR
    Brain Res; 1978 Jun; 149(2):453-67. PubMed ID: 566608
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Lack of effect of cerebellectomy on ascending dopaminergic neurons in the rat brain.
    Lovell KL; Bruner CA; Moore KE
    Neurosci Lett; 1982 Oct; 32(2):187-92. PubMed ID: 7145238
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Axonal transport of proteins and glycoproteins in the rat nigro-striatal pathway and the effects of 6-hydroxydopamine.
    Roger LJ; Breese GR; Morell P
    Brain Res; 1980 Sep; 197(1):95-112. PubMed ID: 6156743
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The effects of nigrostriatal 6-hydroxydopamine lesions on dopamine D2 receptor mRNA and opioid systems.
    Mansour A; Meador-Woodruff JH; Camp DM; Robinson TE; Bunzow J; Van Tol H; Civelli O; Akil H; Watson SJ
    Prog Clin Biol Res; 1990; 328():227-30. PubMed ID: 2106148
    [No Abstract]   [Full Text] [Related]  

  • 30. Rotational behaviour in rats with unilateral striatal kainic acid lesions: a behavioural model for studies on intact dopamine receptors.
    Schwarcz R; Fuxe K; Agnati LF; Hökfelt T; Coyle JT
    Brain Res; 1979 Jul; 170(3):485-95. PubMed ID: 37986
    [TBL] [Abstract][Full Text] [Related]  

  • 31. An analysis at synaptic level of the morphine action in striatum and N. accumbens: dopamine and acetylcholine interactions.
    Costa E; Cheney DL; Racagni G; Zsilla G
    Life Sci; 1975 Jul; 17(1):1-8. PubMed ID: 167253
    [No Abstract]   [Full Text] [Related]  

  • 32. Quantification of lesion-induced dopaminergic supersensitivity using the rotational model in the mouse.
    Mandel RJ; Randall PK
    Brain Res; 1985 Mar; 330(2):358-63. PubMed ID: 3921193
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The relationship between striatal and mesolimbic dopamine dysfunction and the nature of circling responses following 6-hydroxydopamine and electrolytic lesions of the ascending dopamine systems of rat brain.
    Costall B; Marsden CD; Naylor RJ; Pycock CJ
    Brain Res; 1976 Dec; 118(1):87-113. PubMed ID: 990957
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dopaminergic receptor activity in substantia nigra in the mechanisms of autoregulation of striatal dopamine release.
    Groppetti A; Parenti M; Cattabeni F; Maggi A; De Angelis L; Monduzzi M; Racagni G
    Adv Biochem Psychopharmacol; 1978; 19():363-71. PubMed ID: 696464
    [No Abstract]   [Full Text] [Related]  

  • 35. Differential regulation of dopamine metabolism in solid fetal substantia nigra transplants and their terminals in the host striatum.
    Meloni R; Gale K
    Prog Brain Res; 1990; 82():467-71. PubMed ID: 2127112
    [No Abstract]   [Full Text] [Related]  

  • 36. Nigrostriatal dopaminergic activity, deprenyl treatment, and longevity.
    Knoll J
    Adv Neurol; 1990; 53():425-9. PubMed ID: 2122648
    [No Abstract]   [Full Text] [Related]  

  • 37. Dopamine receptor binding enhancement accompanies lesion-induced behavioral supersensitivity.
    Creese I; Burt DR; Snyder SH
    Science; 1977 Aug; 197(4303):596-8. PubMed ID: 877576
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Differential functional ontogeny of dopamine presynaptic receptor regulation.
    Shalaby IA; Dendel PS; Spear LP
    Brain Res; 1981 Jun; 227(3):434-9. PubMed ID: 7260651
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Apomorphine-induced changes in local cerebral blood flow in normal rats and after lesions of the dopaminergic nigrostriatal bundle.
    Ingvar M; Lindvall O; Stenevi U
    Brain Res; 1983 Mar; 262(2):259-65. PubMed ID: 6404503
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Specificity of 6-hydroxydopamine-induced destruction of mesolimbic or nigrostriatal dopamine-containing terminals.
    Kelly PH; Joyce EM; Minneman KP; Phillipson OT
    Brain Res; 1977 Feb; 122(2):382-7. PubMed ID: 189878
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.